Article info

Download PDFPDF
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study

Authors

  1. Correspondence to Dr Fabrizio Cantini, Department of Rheumaotlogy, Hospital of Prato, Prato 59100, Italy; fbrzcantini{at}gmail.com
View Full Text

Citation

Nannini C, Niccoli L, Sestini S, et al
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study

Publication history

  • Received April 21, 2019
  • Revised May 18, 2019
  • Accepted June 8, 2019
  • First published June 18, 2019.
Online issue publication 
September 12, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.